KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Regeneron Pharmaceuticals (REGN) Return on Assets (2016 - 2025)

Historic Return on Assets for Regeneron Pharmaceuticals (REGN) over the last 16 years, with Q4 2025 value amounting to 0.11%.

  • Regeneron Pharmaceuticals' Return on Assets fell 100.0% to 0.11% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.11%, marking a year-over-year decrease of 100.0%. This contributed to the annual value of 0.12% for FY2025, which is 100.0% down from last year.
  • Per Regeneron Pharmaceuticals' latest filing, its Return on Assets stood at 0.11% for Q4 2025, which was down 100.0% from 0.12% recorded in Q3 2025.
  • Regeneron Pharmaceuticals' Return on Assets' 5-year high stood at 0.33% during Q4 2021, with a 5-year trough of 0.11% in Q4 2025.
  • Its 5-year average for Return on Assets is 0.18%, with a median of 0.13% in 2023.
  • As far as peak fluctuations go, Regeneron Pharmaceuticals' Return on Assets surged by 1200bps in 2021, and later plummeted by -1800bps in 2022.
  • Regeneron Pharmaceuticals' Return on Assets (Quarter) stood at 0.33% in 2021, then crashed by -54bps to 0.15% in 2022, then dropped by -21bps to 0.12% in 2023, then fell by -3bps to 0.12% in 2024, then fell by -5bps to 0.11% in 2025.
  • Its Return on Assets stands at 0.11% for Q4 2025, versus 0.12% for Q3 2025 and 0.12% for Q2 2025.